By Conor Hale
The agency granted its first official endorsement, allowing a respiratory panel test from BioFire Diagnostics to be sold into the foreseeable future.
read more
By Heather Landi
Customers at Walmart and Sam's Clubs may soon be able to verify that they have received a COVID-19 vaccine by showing an app on their smartphones. The retail giant announced Wednesday that it will provide access to digital health records, including vaccination information, to people who receive their shots at Walmart and Sam's Clubs.
read more
By Eric Sagonowsky
Eli Lilly and federal officials have been contending with lower-than-expected uptake of COVID-19 antibody therapies. Now, worried about a California coronavirus variant, the government has put Lilly's single-antibody treatment on hold in three states.
read more
By Conor Hale
Roche launched a new COVID-19 test to help researchers monitor emerging variants and track mutations in the coronavirus’s genome that may make the disease more contagious or more deadly.
read more
By Paige Minemyer
The Blue Cross Blue Shield Association is teaming with Feeding America for COVID-19 vaccine outreach in vulnerable communities.
read more
By Beth Snyder Bulik
Pharma's reputation gains during the pandemic—thanks to the concerted rush for vaccines and treatments—is now morphing into long-term business strategies. More and more pharma companies are looking to leverage their rapid scientific progress into a permanent image upgrade.
read more
By Kevin Dunleavy,Fraiser Kansteiner,Eric Sagonowsky,Angus Liu,Conor Hale
The European Medicines Agency has endorsed use of the AstraZeneca COVID-19 vaccine. The U.S. has halted the distribution of Eli Lilly's COVID-19 antibody drug bamlanivimab in 3 states due to concern over variants. And more headlines.
read more
